文献速递脑血管病

芬戈莫德通过促进顺行再灌注和逆行侧支血流增强延迟给予阿替普酶在急性缺血性卒中中的疗效

Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow.
PubMed 文献 · Ann Neurol · 2018-11-02

这项前瞻性随机开放标签盲法终点临床试验纳入症状发作4.5至6小时内颈内动脉或大脑中动脉近端闭塞患者,分别接受单用阿替普酶或阿替普酶联合芬戈莫德治疗,每组23例。联合治疗组24小时早期临床改善和90天改良Rankin量表分布有利偏移均优于单用组。芬戈莫德可能通过促进顺行再灌注和逆行侧支血流增强延迟时间窗内阿替普酶的疗效。

要点

  • 4.5至6小时时间窗内,阿替普酶联合芬戈莫德较单用阿替普酶改善24小时早期临床结局。
  • 联合治疗组90天改良Rankin量表分布呈有利偏移。
  • 芬戈莫德可能通过促进顺行再灌注和逆行侧支血流增强阿替普酶疗效。

核心结论

  • 芬戈莫德可能通过促进顺行再灌注和逆行侧支血流,增强阿替普酶在4.5至6小时时间窗内对近端脑动脉闭塞且有可挽救缺血半暗带患者的疗效。

研究设计与样本

  • 前瞻性、随机、开放标签、盲法终点临床试验,纳入症状发作4.5至6小时内颈内动脉或大脑中动脉近端闭塞患者,随机接受单用阿替普酶或阿替普酶联合芬戈莫德,每组23例。

主要发现

  • 与单用阿替普酶相比,芬戈莫德联合阿替普酶组24小时早期临床改善更好,90天改良Rankin量表分布呈有利偏移。
  • 芬戈莫德联合阿替普酶组24小时灌注病灶缩小更明显,梗死增长受到抑制。
  • 芬戈莫德联合阿替普酶显著改善下游区域顺行再灌注,并防止侧支循环逆行再灌注失败。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The present study was undertaken to determine the efficacy of coadministration of fingolimod with alteplase in acute ischemic stroke patients in a delayed time window. METHODS: This was a prospective, randomized, open-label, blinded endpoint clinical trial, enrolling patients with internal carotid artery or middle cerebral artery proximal occlusion within 4.5 to 6 hours from symptom onset. Patients were randomly assigned to receive alteplase alone or alteplase with fingolimod. All patients underwent pretreatment and 24-hour noncontrast computed tomography (CT)/perfusion CT/CT angiography. The coprimary endpoints were the decrease of National Institutes of Health Stroke Scale scores over 24 hours and the favorable shift of modified Rankin Scale score (mRS) distribution at day 90. Exploratory outcomes included vessel recanalization, anterograde reperfusion, and retrograde reperfusion of collateral flow. RESULTS: Each treatment group included 23 patients. Compared with alteplase alone, patients receiving fingolimod plus alteplase exhibited better early clinical improvement at 24 hours and a favorable shift of mRS distribution at day 90. In addition, patients who received fingolimod and alteplase exhibited a greater reduction in the perfusion lesion accompanied by suppressed infarct growth by 24 hours. Fingolimod in conjunction with alteplase significantly improved anterograde reperfusion of downstream territory and prevented the failure of retrograde reperfusion from collateral circulation. INTERPRETATION: Fingolimod may enhance the efficacy of alteplase administration in the 4.5- to 6-hour time window in patients with a proximal cerebral arterial occlusion and salvageable penumbral tissue by promoting both anterograde reperfusion and retrograde collateral flow. These findings are instructive for the design of future trials of recanalization therapies in extended time windows. Ann Neurol 2018;84:725-736.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Tian DC, Shi K, Zhu Z, et al. Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow. Ann Neurol. 2018. PMID: 30295338. doi:10.1002/ana.25352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。